Skip to main content
. 2012 Dec 20;5(2):210–220. doi: 10.1002/emmm.201201494

Figure 2. Patients with Kawasaki disease but not those with mimicking conditions have significantly elevated serum and urine levels of meprin A and filamin C, which exhibit superior diagnostic performance in a blinded study of patients suspected of KD.

Figure 2

  • A,B. otplots of urine concentrations measured using specific ELISAs of meprin A (A) and filamin C (B) in a blinded case-control study of patients suspected of KD, demonstrating significantly elevated concentrations of meprin A and filamin C in patients with KD (red) as compared to those with non-KD conditions (green) and patients with KD upon receiving IVIg treatment (blue). p = 2.0E−8 and 1.3E−17 for filamin C and meprin A, respectively. Horizontal bars represent means for each comparison group. Note the logarithmic scale of meprin A and filamin C concentrations.
  • C. Receiver operating characteristics of urine meprin A (red) and filamin C (green), as compared to common markers, ESR (dashed black) and blood CRP (solid black).
  • D. Receiver operating characteristic area under the curve (AUC) values and their 95% confidence intervals (CI) for the measured diagnostic markers.
  • E,F. Dotplots of serum concentrations measured using specific ELISAs of meprin A (E) and filamin C (F) in patients with KD (red) as compared to patients with non-KD mimicking conditions (green). p = 1.2E−7 and 3.9E−4 for filamin C and meprin A, respectively.